ViOptix gives clinicians a revolutionary new capability, to obtain non-invasive, objective, real-time measurement of oxygen saturation (StO2) in the soft tissues affected by breast reconstruction and other surgical procedures, to help improve patient surgical outcomes by detecting problems before symptoms are visible.
Together, these products help to improve surgical outcomes, reduce patient time in the ICU, provide clinicians with faster feedback in the event of a problem and save money for the payer.
ViOptix novel technology platform is built into three proprietary products:
Alex Keller, MD
